# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-134970
Filing Date
2019-05-02
Accepted
2019-05-02 16:02:39
Documents
102
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | d724389d10q.htm | 10-Q | 1038934
2 | EX-31.1 | d724389dex311.htm | EX-31.1 | 11231
3 | EX-31.2 | d724389dex312.htm | EX-31.2 | 11240
4 | EX-32 | d724389dex32.htm | EX-32 | 4879
| Complete submission text file | 0001193125-19-134970.txt |  | 14588409

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE DOCUMENT | teva-20190331.xml | EX-101.INS | 5191739
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20190331.xsd | EX-101.SCH | 86284
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20190331_cal.xml | EX-101.CAL | 61699
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20190331_def.xml | EX-101.DEF | 560849
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20190331_lab.xml | EX-101.LAB | 575329
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20190331_pre.xml | EX-101.PRE | 598636

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 19791827
SIC: 2834 Pharmaceutical Preparations